Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-21

Clinical Trial Update: Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer

View source ↗

Summary

This completed clinical trial evaluates whether tamoxifen can prevent bone loss and heart disease in premenopausal women receiving chemotherapy for Stage I or S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamoxifen (tamoxifen)

Snippet

Sponsor: Northwestern University | Conditions: Breast Cancer, Osteoporosis | Status: COMPLETED